July 2006 Issue of MMM
The World Cup is easily my most favorite thing ever. And for reasons too numerous, too complex and too ridiculous to mention.
Continued growth with key wins in both professional and DTC work
Eyeing acquisitions following a good year of revenue-building
Dramatic growth from more than just being in the right place at right time
Explosive growth from a considered approach to service, scale and value
A major Pfizer shop reels in big accounts while thinking small with a spin-off and the launch of a specialty shop
The WPP network gets its ducks in line with a collaborative approach and an inventive foray into marketing research
Well placed after a year of rebranding, diversification and solidification
Emerging from a trans-Atlantic merger, focused and growing
CDM spin-off determined to build a creative haven for talented people
Dermik loss clears pathways to new clients in fresh therapeutic fields
Diverse strategic offerings continue to offer a platform for further growth
Spanning the marketing mix, building a rep for creativity and playing nice
Overcame a year of challenges and uncertainty with impressive launches and bold future plans
Enjoying life after Zocor with a fresh focus on science and niche brands
Innovation and collaborative thinking gets new boutique off to a good start
Several new accounts contribute to a year of "manageable" growth
This year looks like it could more than make up for a disappointing 2005
Solid wins and a global focus vaulted the firm to its best year yet, despite losses on consolidations
Spectacular growth in 2005 renders the Taxotere loss a distant memory
Structural reorganization provides a solid base for growth of agency units
Continued spectacular growth from attempting to redefine healthcare
The network formerly known as inChord comes out of its merger with a new name and its independent spirit intact
Merck vaccines keep three-year-old New York firm busy and buzzing
Continued eye-popping growth for the Bay Area indie built on shared values
Poised to increase scope and size after internal restructure
Preparing to add digital offerings while "digesting" last year's wins
New faces, new ways of doing things stand Omnicom shop in good stead
With double-digit growth, IPG's high-science network is taking advantage of the back-to-basics movement
Global giant with consumer and professional powerhouses seeks to move upstream
Hot on the heels of record growth with a new name and a high-science focus
Perfectly poised to prosper with the backing of new owner Digitas
Miraculously turned the devastating loss of Reliant into a year of growth
Pulling back revenue by focusing on midsize and specialty pharma
One of the world's great advertising names seeks to make its name better known in medical advertising and promotion
Impressive growth within the realms of the West Coast talent pool
The medical advertising behemoth completes a reorganization and rolls on with major-league brands
Explosive growth from a belief in the efficient execution of good ideas
A classic medical advertising agency retools its creative department to ensure many more iconic works to come
Looking to build on two fine years with aggressive plans for growth
Gutsy and triumphant turnaround after losing a third of its business last year
You don't need the greatest mass to make the biggest splash. Marc Iskowitz looks at three smaller agencies whose enthusiasm and fresh thinking have sent ...
The indispensable guide to healthcare agencies, including contacts, rosters, wins and losses, revenues and examples of best work. Agencies submitted their own data as part ...
Ketek is an antibiotic with a deserved reputation as an effective treatment for bacterial respiratory infections.
Staffing concerns topped the list of the biggest challenges facing healthcare agencies in this year's MM&M's agency survey.
Med Ed Report
A new journal, which is intended to discuss the emerging field of outcomes research, is instead struggling to get off the ground.
Physicians prefer exhibits at medical meetings to some other modes of learning about new drugs and technologies, a study suggests.
Integrated Communications, a unit of Lowe Healthcare Worldwide, won a pre-launch med-ed assignment for Ultram ER.
Jobson Education, a former unit of Wicks Healthcare Education & Communications, shuttered.
Physicians Academy for Clinical and Management Excellence has hired Sherlyn Celone and Heidi Katz, RPh, as SVPs of strategic education.
Researchers wrote in The Health Care Manager (25:1) that an analysis of studies of mandatory continuing education (MCE) in medicine and other healthcare fields found ...
MEBN signed an agreement to integrate CME content with Skyscape's mobile medical decision support tools and references.
CMP Healthcare parent United Business Media consolidated its global healthcare operations into CMPMedica, aligning its US healthcare businesses like the Cliggott and Oncology Group journals ...
An article in PLoS Medicine called for medical journals to reject ads from drug companies, saying they compromise the objectivity of journals.
Elsevier has launched Update on Cancer Therapeutics, a quarterly online-only oncology review journal.
John Wiley & Sons is launching Evidence-Based Child Health: A Cochrane Review Journal.
Quadrant HealthCom hired Roxana Aldea as account manager for The Female Patient.
Thomson Healthcare has hired Roseanne McCauley, SVP of sales for PDR.
Marketing places the ads. Sales sells the space. Media acts as the gatekeeper between client and journal. But what should product managers expect from their ...
While pharmaceutical marketers are gradually getting more sophisticated in their use of the Internet—even designing product sites with customers in mind—a recent survey of consumers ...
Informed Medical Communications (IMC), a provider of interactive information services, has named Thomas Patton CEO.
WPP-owned Wunderman has named direct marketing veteran Barry Kessel CEO of RTC Relationship Marketing (RTCRM), its Washington, DC, unit.
Glen Hartman has joined Harte-Hanks as SVP, digital marketing.
PDI signed a deal with an undisclosed major pharmaceutical company to employ 300 sales reps and is expected to reap $35-$40 million, the contract sales ...
AstraZeneca will send out direct-mail communications as part of a larger campaign for its hypertension drug, Toprol-XL.
Medcenter Solutions has named Paul Kelly as CEO.
Xchange, the relationship-marketing unit of CommonHealth, has hired John Clark as EVP, managing director.
The American Medical Association will advocate a mandatory moratorium on consumer advertising for new drugs.
Roche named GSW Worldwide agency of record for Tamiflu DTC work, following a multi-agency pitch involving FCB, Kaplan-Thaler Group, Digitas and Avenue A|Razorfish.
AbelsonTaylor named Holly Wright account supervisor for the firm's DTC/DTP division, reporting to director Richard Blocki.
Shire has awarded Unit 7 the consumer business for its Daytrana ADHD patch.
Deutsch named Matt Dowshen to head the firm's business on Novartis' Zelnorm and Diovan.
Pfizer will hold off on advertising Exubera to consumers for one year while it focuses on education.
The other day a senior FDA official asked me what the agency should do to combat the negative media coverage.
Euro RSCG Life has split its communications practice into product and corporate PR divisions, naming former Ketchum healthcare head David Catlett president of the product ...
A poll suggests that, amid drug safety worries, the FDA is less trusted than the drug industry.
Political meddling in the FDA's scientific decision-making, which began under President Clinton, seems to have cost the agency dearly in public opinion, judging by a ...
Sen. Charles Schumer (D-NY) and Rep. Henry Waxman (D-CA) have called on organizations representing innovator and generic drug companies to take a stance against the ...
With a member of Congress charging that the FDA cares more about contact lens wearers with eye infections than women who die after a medical ...
Advocacy groups led by Commercial Alert, National Women's Health Network, and Physicians for a National Health Program are seeking support for legislation to ban DTC ...
West Virginia's Pharmaceutical Cost Management Council has approved a watered-down version of rules requiring companies to report Rx drug advertising and marketing costs.
In a bench decision, Texas Western District federal judge Robert Junell ruled in May that pharmacy-compounded drugs are not new drugs subject to FDA regulation, ...
It is a fact of life that direct-to-consumer (DTC) promotion has become increasingly educational—as addressed by PhRMA's guidelines for DTC advertising, FDA's public hearing on ...
What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.
A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.